Gesundheitswelt Chiemgau AG is a holding company. The company is engaged in the operation of health resorts and clinics in Bavaria through its subsidiaries.
1.1K+
LTM Revenue n/a
LTM EBITDA n/a
$45.8M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Gesundheitswelt Chiemgau has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Gesundheitswelt Chiemgau achieved revenue of $78.0M and an EBITDA of $9.2M.
Gesundheitswelt Chiemgau expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Gesundheitswelt Chiemgau valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $70.8M | $78.0M | XXX | XXX | XXX |
Gross Profit | $57.1M | $61.1M | XXX | XXX | XXX |
Gross Margin | 81% | 78% | XXX | XXX | XXX |
EBITDA | $9.5M | $9.2M | XXX | XXX | XXX |
EBITDA Margin | 13% | 12% | XXX | XXX | XXX |
Net Profit | $4.4M | $4.3M | XXX | XXX | XXX |
Net Margin | 6% | 5% | XXX | XXX | XXX |
Net Debt | $21.2M | $32.3M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Gesundheitswelt Chiemgau's stock price is EUR 12 (or $13).
Gesundheitswelt Chiemgau has current market cap of EUR 24.2M (or $26.0M), and EV of EUR 42.6M (or $45.8M).
See Gesundheitswelt Chiemgau trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$45.8M | $26.0M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Gesundheitswelt Chiemgau has market cap of $26.0M and EV of $45.8M.
Gesundheitswelt Chiemgau's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Gesundheitswelt Chiemgau's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Gesundheitswelt Chiemgau and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $45.8M | XXX | XXX | XXX |
EV/Revenue | 0.6x | XXX | XXX | XXX |
EV/EBITDA | 5.0x | XXX | XXX | XXX |
P/E | 6.2x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | 6.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpGesundheitswelt Chiemgau's NTM/LTM revenue growth is n/a
Gesundheitswelt Chiemgau's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Gesundheitswelt Chiemgau's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Gesundheitswelt Chiemgau's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Gesundheitswelt Chiemgau and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 10% | XXX | XXX | XXX | XXX |
EBITDA Margin | 12% | XXX | XXX | XXX | XXX |
EBITDA Growth | -3% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 79% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Gesundheitswelt Chiemgau acquired XXX companies to date.
Last acquisition by Gesundheitswelt Chiemgau was XXXXXXXX, XXXXX XXXXX XXXXXX . Gesundheitswelt Chiemgau acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhere is Gesundheitswelt Chiemgau headquartered? | Gesundheitswelt Chiemgau is headquartered in Germany. |
How many employees does Gesundheitswelt Chiemgau have? | As of today, Gesundheitswelt Chiemgau has 1.1K+ employees. |
Is Gesundheitswelt Chiemgau publicy listed? | Yes, Gesundheitswelt Chiemgau is a public company listed on MUN. |
What is the stock symbol of Gesundheitswelt Chiemgau? | Gesundheitswelt Chiemgau trades under JTH ticker. |
When did Gesundheitswelt Chiemgau go public? | Gesundheitswelt Chiemgau went public in 2000. |
Who are competitors of Gesundheitswelt Chiemgau? | Similar companies to Gesundheitswelt Chiemgau include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
What is the current market cap of Gesundheitswelt Chiemgau? | Gesundheitswelt Chiemgau's current market cap is $26.0M |
What is the current revenue growth of Gesundheitswelt Chiemgau? | Gesundheitswelt Chiemgau revenue growth between 2023 and 2024 was 10%. |
Is Gesundheitswelt Chiemgau profitable? | Yes, Gesundheitswelt Chiemgau is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.